Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.8M | 3.9M | 3.8M | 3.9M |
| Cost of revenue | 1.3M | 1.3M | 1.3M | 1.2M |
| Gross profit | 2.5M | 2.6M | 2.5M | 2.7M |
| Operating expense | ||||
| Research & development | 961K | 1.1M | 1.1M | 1.0M |
| Selling general and admin | 2.1M | 1.9M | 1.8M | 1.8M |
| Other operating expenses | — | — | — | — |
| Operating income | -679K | -548K | -501K | -340K |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | 5K | 4K | — |
| Other income expense | -105K | -172K | -124K | -89K |
| Pretax income | -784K | -725K | -629K | -490K |
| Tax provision | 5K | 5K | 5K | -58K |
| Net income | -789K | -730K | -634K | -432K |
| Basic EPS | -0.1 | -0.1 | -0.1 | — |
| Diluted EPS | -0.1 | -0.1 | -0.1 | — |
| Basic average shares | 11.9M | 10.5M | 10.4M | — |
| Diluted average shares | 11.9M | 10.5M | 10.4M | — |
| EBITDA | -376K | -346K | -300K | -177K |
| Net income from continuing op. | -789K | -730K | -634K | -432K |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |